Human Early Prostate Cancer Antigen 2 ELISA Kit is a sandwich Enzyme-Linked Immunosorbent Assay (sELISA) designed for the in vitro quantitative determination of human Early Prostate Cancer Antigen 2 in serum, plasma, tissue homogenates, and other biological fluids.
Detektionsbereich:
6.25-400 ng/ml
Sensitivitaet:
3.75 ng/ml
Proben:
Serum, plasma, tissue homogenates, and other biological fluids.
Target-Kategorie:
Early Prostate Cancer Antigen 2
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
